Literature DB >> 22689696

Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors.

Michaël Grynberg1, Alice Pierre, Rodolfo Rey, Arnaud Leclerc, Nassim Arouche, Laetitia Hesters, Sophie Catteau-Jonard, René Frydman, Jean-Yves Picard, Renato Fanchin, Reiner Veitia, Nathalie di Clemente, Joëlle Taieb.   

Abstract

BACKGROUND: Anti-müllerian hormone (AMH) is a member of the TGF-β family, which limits follicle maturation. Recently serum AMH has been recognized as a useful diagnostic and prognostic tool in human reproductive endocrinology.
OBJECTIVE: The aim of this study was to investigate the regulation of human ovarian AMH by estradiol and FSH.
METHODS: AMH mRNA were quantified by real time RT-PCR in human granulosa cells (GC). AMH transcription was studied in KK1 GC cotransfected with estrogen receptors (ER)-β or ERα, and normal human AMH promoter-luciferase construct (hAMH-luc) or mutated AMH promoter reporter constructs. Binding sites for estradiol (estrogen response element half-site) and steroidogenic factor 1 were disrupted by targeted mutagenesis. The level of ER in GC was determined by quantitative RT-PCR and Western blotting.
RESULTS: In KK1 cells, estradiol up-regulated and inhibited hAMH-luc in the presence of ERα and ERβ respectively. Disruption of estrogen response element half-site and/or steroidogenic factor 1 binding sites did not modify ERβ-mediated effect of estradiol on hAMH-luc, whereas it affected that conveyed by ERα. The FSH enhancement of hAMH-luc was abolished by estradiol in cells overexpressing ERβ. When both ER were transfected, estradiol inhibited hAMH-luc or had no effect. Estradiol repressed AMH mRNAs in human GC, which express a little more ERα than ERβ mRNA.
CONCLUSIONS: Our results show that AMH expression can be differentially regulated by estradiol depending on the ER and suggest that its decrease in GC of growing follicles, which mainly express ERβ, and during controlled ovarian hyperstimulation is due to the effect of estradiol.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689696     DOI: 10.1210/jc.2011-3133

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome.

Authors:  Jingwen Hou; Heidi Cook-Andersen; H Irene Su; Rana Shayya; Kevin H Maas; Christine M Burt-Solorzano; Ajay Kumar; R Jeffrey Chang
Journal:  J Pediatr Endocrinol Metab       Date:  2016-07-01       Impact factor: 1.634

2.  Testicular development in male rats is sensitive to a soy-based diet in the neonatal period.

Authors:  India D Napier; Liz Simon; Devin Perry; Paul S Cooke; Douglas M Stocco; Estatira Sepehr; Daniel R Doerge; Barbara W Kemppainen; Edward E Morrison; Benson T Akingbemi
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

3.  Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells.

Authors:  Sambit Roy; Divya Gandra; Christina Seger; Anindita Biswas; Vitaly A Kushnir; Norbert Gleicher; T Rajendra Kumar; Aritro Sen
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

4.  AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women.

Authors:  Madison T Ortega; Lauren Carlson; John A McGrath; Tairmae Kangarloo; Judith Mary Adams; Patrick M Sluss; Geralyn Lambert-Messerlian; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells.

Authors:  Scott Convissar; Marah Armouti; Michelle A Fierro; Nicola J Winston; Humberto Scoccia; A Musa Zamah; Carlos Stocco
Journal:  Reproduction       Date:  2017-09-05       Impact factor: 3.906

6.  Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.

Authors:  Kevin H Maas; Sandy S Chuan; Heidi Cook-Andersen; H Irene Su; A Duleba; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

Review 7.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

8.  Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.

Authors:  Aviva B Sopher; Galina Grigoriev; Diana Laura; Tamara Cameo; Jodi P Lerner; R Jeffrey Chang; Donald J McMahon; Sharon E Oberfield
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

9.  Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.

Authors:  Heidi Cook-Andersen; Sandy S Chuan; Kevin Maas; Marcus A Rosencrantz; H Irene Su; Mark Lawson; Helen D Mason; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

10.  A novel, noncoding-RNA-mediated, post-transcriptional mechanism of anti-Mullerian hormone regulation by the H19/let-7 axis.

Authors:  Chunrong Qin; Xi Xia; Yanhong Fan; Ying Jiang; Yong Chen; Na Zhang; Bahar Uslu; Joshua Johnson; Amanda N Kallen
Journal:  Biol Reprod       Date:  2019-01-01       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.